This differed from our result that NCAPD3 inhibited miR-30a-5p expression, which was regulated by AR signaling, indicating antitumor miR-30a might function in both androgen-dependent and independent states associated with prostate cancer progression. The gene discussed is NCAPD3; the disease is prostate carcinoma.